Roadblocks in Chagas disease care in endemic and nonendemic countries: Argentina, Colombia, Spain, and the United States. The NET-Heart project
Open Access
- 30 December 2021
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Neglected Tropical Diseases
- Vol. 15 (12), e0009954
- https://doi.org/10.1371/journal.pntd.0009954
Abstract
Chagas disease (CD) is endemic in Latin America; however, its spread to nontropical areas has raised global interest in this condition. Barriers in access to early diagnosis and treatment of both acute and chronic infection and their complications have led to an increasing disease burden outside of Latin America. Our goal was to identify those barriers and to perform an additional analysis of them based on the Inter American Society of Cardiology (SIAC) and the World Heart Federation (WHF) Chagas Roadmap, at a country level in Argentina, Colombia, Spain, and the United States, which serve as representatives of endemic and nonendemic countries. This is a nonsystematic review of articles published in indexed journals from 1955 to 2021 and of gray literature (local health organizations guidelines, local policies, blogs, and media). We classified barriers to access care as (i) existing difficulties limiting healthcare access; (ii) lack of awareness about CD and its complications; (iii) poor transmission control (vectorial and nonvectorial); (iv) scarce availability of antitrypanosomal drugs; and (v) cultural beliefs and stigma. Region-specific barriers may limit the implementation of roadmaps and require the application of tailored strategies to improve access to appropriate care. Multiple barriers negatively impact the prognosis of CD. Identification of these roadblocks both nationally and globally is important to guide development of appropriate policies and public health programs to reduce the global burden of this disease. Chagas disease (CD) has been described as an epidemic in Latin America, but its geographical influence is global. One of the biggest challenges in providing care for patients with CD is to improve access to early diagnosis and treatment in order to avoid chronic cardiovascular and gastrointestinal complications. However, different roadblocks interfere with the optimal care of these patients, which facilitates disease progression. While some barriers to care are global in scope, there are additionally national and even local obstacles for patients with CD. Appropriate delineation of these barriers will allow for the development of targeted interventions to improve the outlook for CD patients in both endemic and nonendemic countries alike.Keywords
This publication has 35 references indexed in Scilit:
- Opportunity Cost for Early Treatment of Chagas Disease in MexicoPLoS Neglected Tropical Diseases, 2014
- Recomendaciones para el diagnóstico, seguimiento y tratamiento de la embarazada y del niño con enfermedad de ChagasEnfermedades Infecciosas y Microbiología Clínica, 2013
- Socio-Cultural Aspects of Chagas Disease: A Systematic Review of Qualitative ResearchPLoS Neglected Tropical Diseases, 2013
- Migration and health in an increasingly diverse EuropeThe Lancet, 2013
- Guidelines on the Treatment of Chronic Coinfection byTrypanosoma cruziand HIV Outside Endemic AreasHIV Research & Clinical Practice, 2011
- Trypanosoma cruzi and Chagas' Disease in the United StatesClinical Microbiology Reviews, 2011
- Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areasTransplantation Reviews, 2011
- Chagas disease in Spain, the United States and other non-endemic countriesActa Tropica, 2010
- Diagnosis, management and treatment of chronic Chagas’ gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemicGastroenterología y Hepatología, 2010
- Incidence of Newly Detected Atrial Arrhythmias via Implantable Devices in Patients With a History of Thromboembolic EventsStroke, 2010